Healthcare Services

Fatty Liver Treatment Market to Reach $35.67B by 2030

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Fatty Liver Treatment Market During 2026–2030?

The fatty liver treatment market size has seen significant growth in recent years. It is projected to expand from $25.05 billion in 2025 to $26.75 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.8%. This historical growth can be attributed to factors such as increasing obesity rates, the rising prevalence of diabetes, advancements in liver diagnostic tools, heightened awareness of liver health, and the expansion of hepatology clinics.

The fatty liver treatment market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $35.67 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.5%. Factors contributing to this growth during the forecast period include the introduction of innovative NAFLD medications, a rise in the adoption of non-invasive diagnostic methods, the expansion of preventive healthcare initiatives, the increasing availability of tele-hepatology services, and greater investment in research related to liver diseases. Key trends observed in this period encompass the growing incidence of non-alcoholic fatty liver disease, an amplified emphasis on lifestyle-centric treatment strategies, the increasing application of targeted drug therapies, broader early screening for liver conditions, and the incorporation of digital health solutions for monitoring the disease.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report

What Key Factors Are Shaping The Fatty Liver Treatment Market Landscape?

Rising alcohol intake is anticipated to drive expansion in the fatty liver treatment market in the future. Alcohol consumption involves the intake of drinks that contain alcohol, which is a psychoactive compound known for its depressant impact on the central nervous system. The intake of alcohol has the potential to aggravate fatty liver disease and contribute to the development of more severe hepatic conditions, such as alcoholic fatty liver disease (AFLD) and alcoholic hepatitis. As an illustration, in November 2025, data from the OECD, a Paris-based intergovernmental organization, indicated that the average annual per capita alcohol consumption among its member nations in 2023 was 8.5 liters of pure alcohol. Consequently, the rising levels of alcohol intake are fueling the expansion of the fatty liver treatment market.

How Is Segmentation Applied In The Fatty Liver Treatment Market Segment Analysis?

The fatty liver treatment market covered in this report is segmented –

1) By Treatment Type: Anti-Viral Drugs, Chemotherapy Drugs, Targeted Therapy, Anti-Fibrotic Drugs

2) By Disease Type: Hepatitis, Liver Cancer, Non-Alcoholic Fatty Liver Disease, Other Diseases

3) By End User: Hospitals, Ambulatory Surgery Centers, Other End Users

Subsegments:

1) By Anti-Viral Drugs: Direct-Acting Antivirals (DAAs), Nucleos(t)ide Analogs

2) By Chemotherapy Drugs: Conventional Chemotherapy Agents, Novel Chemotherapeutics Under Investigation

3) By Targeted Therapy: Small Molecule Inhibitors, Monoclonal Antibodies

4) By Anti-Fibrotic Drugs: PPAR Agonists, FXR Agonists, GLP-1 Receptor Agonists, SGLT2 Inhibitors, Other Insulin Sensitizers

What Market Trends Are Affecting The Fatty Liver Treatment Market?

Leading firms within the fatty liver treatment market are prioritizing the creation of novel solutions, including advanced metabolic-modulating biologics, to satisfy the growing need for potent treatments that address the core mechanisms of NAFLD and NASH. Such biologic therapies engage critical metabolic and inflammatory pathways, presenting a more precise and disease-altering method versus conventional lifestyle-focused interventions, which offer restricted therapeutic benefit in advanced stages. As an example, in March 2023, Akero Therapeutics, a biotechnology company based in the US, announced favorable Phase II results for efruxifermin, intended for managing non-invasively diagnosed nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). This compound is a distinct Fc-FGF21 fusion protein designed to replicate the biological action of fibroblast growth factor 21 (FGF21), an agent that regulates various metabolic pathways and cellular processes.

Who Are The Companies Participating In The Fatty Liver Treatment Market Environment?

Major companies operating in the fatty liver treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Hoffmann La Roche Ltd., AstraZeneca plc, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., The Bristol-Myers Squibb Company, Gilead Sciences Inc., Novo Nordisk A/S, Intercept Pharmaceuticals Inc., Madrigal Pharmaceuticals Inc., Genfit, Conatus Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Cardax Inc., Eisai Co. Ltd., Alnylam Pharmaceuticals Inc.

Get The Full Fatty Liver Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report

Which Geographic Region Dominates The Fatty Liver Treatment Market?

North America was the largest region in the fatty liver treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fatty liver treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Fatty Liver Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report

Browse Through More Reports Similar to the Global Fatty Liver Treatment Market 2026, By The Business Research Company

Non Alcoholic Steatohepatitis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-treatment-global-market-report

Liver Diseases Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Liver Metastases Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-metastases-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795